GGrantIndex
Sort

146,196 grants matching diabetes

COOPERATIVE MULTICENTER MFM UNITS NETWORK

$998,832
Women And Infants Hospital-Rhode Island · U10 · FY2002 · HD

Protecting Pancreatic Islet Grafts from Rejection

$998,749
Uwe D. Staerz · Isogenis, Inc. · R44 · FY2007 · DK

Nonpeptide, oral somatostatin agonists for congenital hyperinsulinemias

$998,741
Stephen F Betz · Crinetics Pharmaceuticals, Inc. · R44 · FY2018 · DK

Clinical Evaluation of a Long Term Implanted Glucose Sensor

$998,705
Joseph Y. Lucisano · Glysens, Inc. · R44 · FY2009 · DK

Expanding Infrastructure for Community-Academic Research Partnerships in Detroit

$998,697
Barbara A Israel · University Of Michigan At Ann Arbor · RC4 · FY2010 · MD

A Novel Probiotic for the Treatment of Sjogren's Syndrome

$998,658
Gary Fanger · Rise Therapeutics, Llc · SB1 · FY2021 · DE

Treatment of Preserved Systolic Function with an Aldosterone Antagonist

$998,642
Rebecca Li · New England Research Institutes, Inc. · N01 · FY2014 · HL

The Kentucky Diabetes and Obesity Collaborative (KDOC)

$998,571
Kevin A Pearce · University Of Kentucky · RC4 · FY2010 · DK

Development of a first-in-class therapeutic for producing 'on-demand' voiding

$998,525
Karl B Thor · Dignify Therapeutics, Llc · R44 · FY2019 · DK

Development of MRS-2541, a methionyl-tRNA synthetase inhibitor, for Gram positive bacterial infections.

$998,521
Elke Lipka · Tsrl, Inc. · R44 · FY2023 · AI

NEI Genetic Engineering Core

$998,433
Lijin Dong · National Eye Institute · ZIC · FY2011 · EY

Relating Molecular Subgroups of Endometriosis-Associated Ovarian Cancers to Survival and Risk

$998,385
Ellen L. Goode · Mayo Clinic Rochester · R01 · FY2023 · CA

Novel Manufacturing Processes for Tissue Engineered Vascular Grafts

$998,367
Shannon L. M. Dahl · Humacyte, Inc. · R44 · FY2013 · HL

STTR Phase II: Intravitreal oxygen nanobubble technology for treatment of retinal artery occlusions

$998,356
Mathew Cherian · Revive Biotechnology Inc. · · FY2023 · TIP

A 3D vascularized islet biomimetic to model type 1 diabetes

$998,312
Maike Sander · University Of California, San Diego · UH3 · FY2023 · DK

Relating Molecular Subgroups of Endometriosis-Associated Ovarian Cancers to Survival and Risk

$998,304
Ellen L. Goode · Mayo Clinic Rochester · R01 · FY2022 · CA

Clinical Evaluation of a Long Term Implanted Glucose Sensor

$998,304
Joseph Y. Lucisano · Glysens, Inc. · R44 · FY2010 · DK

Tissue Perfusion and Blood Flow Monitoring Technology

$998,293
Leonard William Winchester · Cw Optics, Inc. · R44 · FY2007 · HL

Chronic Kidney Disease in Children (CKiD III)

$998,262
Bradley Alan Warady · Children'S Mercy Hosp (Kansas City, Mo) · U01 · FY2016 · DK

Selective Depletion of Insulin-Specific B cells to Prevent Type 1 Diabetes

$998,123
Todd C Zion · Akston Biosciences Corporation · R44 · FY2017 · DK

Protecting Pancreatic Islet Grafts from Rejection

$998,068
Uwe D. Staerz · Isogenis, Inc. · R44 · FY2008 · DK

Continuation of the Symptoms of Lower Urinary Tract Dysfunction Research Network (LURN) Data Coordinating Center

$998,039
John Joseph Graff · Arbor Research Collaborative For Health · U24 · FY2025 · DK

The HOPE App: An Immersive Telehealth Solution for Older Adults with Diabetes

$997,968
Suzanne Mitchell · See Yourself Health, Llc · R44 · FY2022 · AG

Strong Heart Family Study

$997,736
Jean W Maccluer · Texas Biomedical Research Institute · U01 · FY2006 · HL

Medical Retina Fellowship

$997,688
Catherine Cukras · National Eye Institute · ZIE · FY2022 · EY